Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification
This study highlights the importance of considering both clinical and molecular factors in the management of glioma patients to improve cognitive outcomes.
Source: Journal of Molecular Neuroscience - Category: Neuroscience Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Genetics | Glioma | International Medicine & Public Health | Men | Neurology | Neuroscience | Study | WHO